Sign In

Login

Password

Forgot Password ? Sign Up

Rho-sõltuv proteiinkinaas (Estonian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Rho-sõltuv proteiinkinaas" in Estonian language version.

refsWebsite
Global rank Estonian rank
19nih.gov
4th place
14th place
18doi.org
2nd place
16th place
1archive.org
6th place
41st place

archive.org

doi.org

  • Liao JK, Seto M, Noma K (2007). "Rho kinase (ROCK) inhibitors". J Cardivasc Pharm. 50 (1): 17–24. DOI:10.1097/FJC.0b013e318070d1bd. PMID 17666911.{{cite journal}}: CS1 hooldus: mitu nime: autorite loend (link)
  • Liao JK, Amano M, Nakayama M, Kaibuchi K (2010). "Rho-kinase/ROCK: A key regulator of the cytoskeleton and cell polarity". Cytosceleton. 67 (9): 545–554. DOI:10.1002/cm.20472. PMID 20803696.{{cite journal}}: CS1 hooldus: mitu nime: autorite loend (link)
  • Shimokawa H, Rashid M (2007). "Development of Rho-kinase inhibitors for cardiovascular medicine". Trends Pharmacol Sci. 28 (6): 545–554. DOI:10.1016/j.tips.2007.04.006. PMID 17482681.
  • Riento K, Ridley AJ (2003). "Rocks: multifunctional kinases in cell behaviour". Trends Pharmacol Sci. 4 (6): 446–456. DOI:10.1038/nrm1128. PMID 12778124.
  • Amano M, Fukata Y, Kaibuchi K (2000). "Regulation and functions of Rho-associated kinase". FEBS Lett. 392 (2): 189–193. DOI:10.1006/excr.2000.5046. PMID 11082274.{{cite journal}}: CS1 hooldus: mitu nime: autorite loend (link)
  • LoGrasso PV, Feng Y (2009). "Regulation and functions of Rho-associated kinase". Curr Top Med Chem. 8 (9): 704–723. DOI:10.2174/156802609789044452. PMID 19689376.
  • Hahmann c, Schroeter T (2010). "Rho-kinase inhibitors as therapeutics: from pan inhibition to isoform selectivity". Cell Mol Life Sci. 67 (2): 171–177. DOI:10.1007/s00018-009-0189-x. PMID 19907920.
  • Nakagawa O, Fujisawa K, Ishizaki T, Saito Y, Nakao K, Narumiya S (1996). "ROCK-I and ROCK-II, two isoforms of Rho-associated coiled-coil forming protein serine/threonine kinase in mice". FEBS Lett. 392 (2): 189–193. DOI:10.1016/0014-5793(96)00811-3. PMID 8772201.{{cite journal}}: CS1 hooldus: mitu nime: autorite loend (link)
  • Murthy KS (2006). "Signaling for contraction and relaxation in smooth muscle of the gut". Annu Rev Physiol. 68: 345–374. DOI:10.1146/annurev.physiol.68.040504.094707. PMID 16460276.
  • Kaibuchi K, Kuroda S, Amano M (1999). "Regulation of the cytoskeleton and cell adhesion by the Rho family GTPases in mammalian cells". Annu Rev Biochem. 68: 459–486. DOI:10.1146/annurev.biochem.68.1.459. PMID 10872457.{{cite journal}}: CS1 hooldus: mitu nime: autorite loend (link)
  • Somlyo AP, Somlyo AV (2000). "Signal transduction by G-proteins, rho-kinase and protein phosphatase to smooth muscle and non-muscle myosin II". J Physiol. 522 (2): 177–185. DOI:DOI: 10.1111/j.1469-7793.2000.t01-2-00177.x. PMID 10639096. {{cite journal}}: kontrolli parameetri |doi= väärtust (juhend)
  • Jacobs M, Hayakawa K, Swenson L, Bellon S, Fleming M, Taslimi P, Doran J (2006). "The structure of dimeric ROCK I reveals the mechanism for ligand selectivity". Annu Rev Biochem. 281 (1): 260–268. DOI:10.1074/jbc.M508847200. PMID 16249185.{{cite journal}}: CS1 hooldus: mitu nime: autorite loend (link)
  • Smith CM, Radzio-Andzelm E, Madhusudan, Akamine P, Taylor SS (1999). "The catalytic subunit of cAMP-dependent protein kinase: prototype for an extended network of communication". Prog Biophys Mol Biol. 71 (3–4): 313–341. DOI:10.1016/S0079-6107(98)00059-5. PMID 10354702.{{cite journal}}: CS1 hooldus: mitu nime: autorite loend (link)
  • Shi J, Wei L (2007). "Rho kinase in the regulation of cell death and survival". Arch Immunol Ther Exp. 55 (2): 61–75. DOI:10.1007/s00005-007-0009-7. PMID 17347801.
  • Maekawa M, Ishizaki T, Boku S, Watanabe N, Fujita A, Iwamatsu A, Obinata T, Ohashi K, Mizuno K, Narumiya S (1999). "Signaling from Rho to the actin cytoskeleton through protein kinases ROCK and LIM-kinase". Science. 285 (5429): 895–898. DOI:10.1126/science.285.5429.895. PMID 10436159.{{cite journal}}: CS1 hooldus: mitu nime: autorite loend (link)
  • Fukata Y, Amano M, Kaibuchi K (2001). "Rho-Rho-kinase pathway in smooth muscle contraction and cytoskeletal reorganization of non-muscle cells". Trends Pharmacol Sci. 22 (1): 32–39. DOI:10.1016/S0165-6147(00)01596-0. PMID 11165670.{{cite journal}}: CS1 hooldus: mitu nime: autorite loend (link)
  • Cohen P (2002). "Protein kinases-the major drug targets of the twenty-first century?". Nat Rev Drug Discov. 1 (4): 309–315. DOI:10.1038/nrd773. PMID 11165670.
  • Satoh K, Fukumoto Y, Shimokawa H (2011). "Rho-kinase: important new therapeutic target in cardiovascular diseases". Am J Physiol Heart Circ Physiol. 301 (2): H287–H296. DOI:10.1152/ajpheart.00327.2011. PMID 21622831.{{cite journal}}: CS1 hooldus: mitu nime: autorite loend (link)

nih.gov

pubmed.ncbi.nlm.nih.gov

  • Liao JK, Seto M, Noma K (2007). "Rho kinase (ROCK) inhibitors". J Cardivasc Pharm. 50 (1): 17–24. DOI:10.1097/FJC.0b013e318070d1bd. PMID 17666911.{{cite journal}}: CS1 hooldus: mitu nime: autorite loend (link)
  • Liao JK, Amano M, Nakayama M, Kaibuchi K (2010). "Rho-kinase/ROCK: A key regulator of the cytoskeleton and cell polarity". Cytosceleton. 67 (9): 545–554. DOI:10.1002/cm.20472. PMID 20803696.{{cite journal}}: CS1 hooldus: mitu nime: autorite loend (link)
  • Shimokawa H, Rashid M (2007). "Development of Rho-kinase inhibitors for cardiovascular medicine". Trends Pharmacol Sci. 28 (6): 545–554. DOI:10.1016/j.tips.2007.04.006. PMID 17482681.
  • Riento K, Ridley AJ (2003). "Rocks: multifunctional kinases in cell behaviour". Trends Pharmacol Sci. 4 (6): 446–456. DOI:10.1038/nrm1128. PMID 12778124.
  • Amano M, Fukata Y, Kaibuchi K (2000). "Regulation and functions of Rho-associated kinase". FEBS Lett. 392 (2): 189–193. DOI:10.1006/excr.2000.5046. PMID 11082274.{{cite journal}}: CS1 hooldus: mitu nime: autorite loend (link)
  • LoGrasso PV, Feng Y (2009). "Regulation and functions of Rho-associated kinase". Curr Top Med Chem. 8 (9): 704–723. DOI:10.2174/156802609789044452. PMID 19689376.
  • Hahmann c, Schroeter T (2010). "Rho-kinase inhibitors as therapeutics: from pan inhibition to isoform selectivity". Cell Mol Life Sci. 67 (2): 171–177. DOI:10.1007/s00018-009-0189-x. PMID 19907920.
  • Nakagawa O, Fujisawa K, Ishizaki T, Saito Y, Nakao K, Narumiya S (1996). "ROCK-I and ROCK-II, two isoforms of Rho-associated coiled-coil forming protein serine/threonine kinase in mice". FEBS Lett. 392 (2): 189–193. DOI:10.1016/0014-5793(96)00811-3. PMID 8772201.{{cite journal}}: CS1 hooldus: mitu nime: autorite loend (link)
  • Murthy KS (2006). "Signaling for contraction and relaxation in smooth muscle of the gut". Annu Rev Physiol. 68: 345–374. DOI:10.1146/annurev.physiol.68.040504.094707. PMID 16460276.
  • Kaibuchi K, Kuroda S, Amano M (1999). "Regulation of the cytoskeleton and cell adhesion by the Rho family GTPases in mammalian cells". Annu Rev Biochem. 68: 459–486. DOI:10.1146/annurev.biochem.68.1.459. PMID 10872457.{{cite journal}}: CS1 hooldus: mitu nime: autorite loend (link)
  • Somlyo AP, Somlyo AV (2000). "Signal transduction by G-proteins, rho-kinase and protein phosphatase to smooth muscle and non-muscle myosin II". J Physiol. 522 (2): 177–185. DOI:DOI: 10.1111/j.1469-7793.2000.t01-2-00177.x. PMID 10639096. {{cite journal}}: kontrolli parameetri |doi= väärtust (juhend)
  • Jacobs M, Hayakawa K, Swenson L, Bellon S, Fleming M, Taslimi P, Doran J (2006). "The structure of dimeric ROCK I reveals the mechanism for ligand selectivity". Annu Rev Biochem. 281 (1): 260–268. DOI:10.1074/jbc.M508847200. PMID 16249185.{{cite journal}}: CS1 hooldus: mitu nime: autorite loend (link)
  • Kennelly PJ, Krebs EG (1991). "Consensus sequences as substrate specificity determinants for protein kinases and protein phosphatases". J Biol Chem. 266 (24): 15555–15558. PMID 1651913.
  • Smith CM, Radzio-Andzelm E, Madhusudan, Akamine P, Taylor SS (1999). "The catalytic subunit of cAMP-dependent protein kinase: prototype for an extended network of communication". Prog Biophys Mol Biol. 71 (3–4): 313–341. DOI:10.1016/S0079-6107(98)00059-5. PMID 10354702.{{cite journal}}: CS1 hooldus: mitu nime: autorite loend (link)
  • Shi J, Wei L (2007). "Rho kinase in the regulation of cell death and survival". Arch Immunol Ther Exp. 55 (2): 61–75. DOI:10.1007/s00005-007-0009-7. PMID 17347801.
  • Maekawa M, Ishizaki T, Boku S, Watanabe N, Fujita A, Iwamatsu A, Obinata T, Ohashi K, Mizuno K, Narumiya S (1999). "Signaling from Rho to the actin cytoskeleton through protein kinases ROCK and LIM-kinase". Science. 285 (5429): 895–898. DOI:10.1126/science.285.5429.895. PMID 10436159.{{cite journal}}: CS1 hooldus: mitu nime: autorite loend (link)
  • Fukata Y, Amano M, Kaibuchi K (2001). "Rho-Rho-kinase pathway in smooth muscle contraction and cytoskeletal reorganization of non-muscle cells". Trends Pharmacol Sci. 22 (1): 32–39. DOI:10.1016/S0165-6147(00)01596-0. PMID 11165670.{{cite journal}}: CS1 hooldus: mitu nime: autorite loend (link)
  • Cohen P (2002). "Protein kinases-the major drug targets of the twenty-first century?". Nat Rev Drug Discov. 1 (4): 309–315. DOI:10.1038/nrd773. PMID 11165670.
  • Satoh K, Fukumoto Y, Shimokawa H (2011). "Rho-kinase: important new therapeutic target in cardiovascular diseases". Am J Physiol Heart Circ Physiol. 301 (2): H287–H296. DOI:10.1152/ajpheart.00327.2011. PMID 21622831.{{cite journal}}: CS1 hooldus: mitu nime: autorite loend (link)